115 related articles for article (PubMed ID: 16114855)
21. Zotarolimus (ABT-578) eluting stents.
Burke SE; Kuntz RE; Schwartz LB
Adv Drug Deliv Rev; 2006 Jun; 58(3):437-46. PubMed ID: 16581153
[TBL] [Abstract][Full Text] [Related]
22. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Bhargava B; Reddy NK; Karthikeyan G; Raju R; Mishra S; Singh S; Waksman R; Virmani R; Somaraju B
Catheter Cardiovasc Interv; 2006 May; 67(5):698-702. PubMed ID: 16575925
[TBL] [Abstract][Full Text] [Related]
23. The paclitaxel-eluting stent in percutaneous coronary intervention: part I: background and clinical comparison to bare metal stents.
Gruchalla KJ; Nawarskas JJ
Cardiol Rev; 2006; 14(2):88-98. PubMed ID: 16493246
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of drug-eluting stents: current best available evidence.
Raja SG; Dreyfus GD
J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
[TBL] [Abstract][Full Text] [Related]
25. Therapy insight: diabetes and drug-eluting stents.
Legrand V
Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):143-50. PubMed ID: 17330126
[TBL] [Abstract][Full Text] [Related]
26. Heparin-coating of coronary stents.
van der Giessen WJ; van Beusekom HM; Eijgelshoven MH; Morèl MA; Serruys PW
Semin Interv Cardiol; 1998; 3(3-4):173-6. PubMed ID: 10406689
[TBL] [Abstract][Full Text] [Related]
27. The road to bioabsorbable stents: reaching clinical reality?
Erne P; Schier M; Resink TJ
Cardiovasc Intervent Radiol; 2006; 29(1):11-6. PubMed ID: 16195840
[TBL] [Abstract][Full Text] [Related]
28. Update on bioabsorbable stents: from bench to clinical.
Waksman R
J Interv Cardiol; 2006 Oct; 19(5):414-21. PubMed ID: 17020566
[TBL] [Abstract][Full Text] [Related]
29. The pathophysiology and burden of restenosis.
Weintraub WS
Am J Cardiol; 2007 Sep; 100(5A):3K-9K. PubMed ID: 17719351
[TBL] [Abstract][Full Text] [Related]
30. New drug-eluting stents, optimizing technique, and the problem of drug-eluting stent restenosis.
Vaina S; Ong AT; Serruys PW
Minerva Cardioangiol; 2005 Oct; 53(5):341-60. PubMed ID: 16179880
[TBL] [Abstract][Full Text] [Related]
31. Stent coating: a new approach in interventional cardiology.
Wieneke H; Sawitowski T; Wnendt S; Fischer A; Dirsch O; Karoussos IA; Erbel R
Herz; 2002 Sep; 27(6):518-26. PubMed ID: 12378397
[TBL] [Abstract][Full Text] [Related]
32. Drug-eluting stents: a comprehensive appraisal.
Butt M; Connolly D; Lip GY
Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
[TBL] [Abstract][Full Text] [Related]
33. MOONLIGHT: a controlled registry of an iridium oxide-coated stent with angiographic follow-up.
Di Mario C; Grube E; Nisanci Y; Reifart N; Colombo A; Rodermann J; Muller R; Umman S; Liistro F; Montorfano M; Alt E
Int J Cardiol; 2004 Jun; 95(2-3):329-31. PubMed ID: 15193840
[No Abstract] [Full Text] [Related]
34. Drug-eluting stents: preventing restenosis.
Slavin L; Chhabra A; Tobis JM
Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
[TBL] [Abstract][Full Text] [Related]
35. From randomized trials to routine clinical practice: an evidence-based approach for the use of drug-eluting stents.
Thanigaraj S; Wollmuth JR; Zajarias A; Chemmalakuzhy J; Lasala JM
Coron Artery Dis; 2006 Dec; 17(8):673-9. PubMed ID: 17119375
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
37. [Development of drug coating on drug eluting stents].
Luo LL; Wang GX; Yin TY
Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
Carter AJ
Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
[No Abstract] [Full Text] [Related]
39. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
[TBL] [Abstract][Full Text] [Related]
40. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
